JPH10501792A - カプセル化細胞の宿主への移植方法 - Google Patents
カプセル化細胞の宿主への移植方法Info
- Publication number
- JPH10501792A JPH10501792A JP7527082A JP52708295A JPH10501792A JP H10501792 A JPH10501792 A JP H10501792A JP 7527082 A JP7527082 A JP 7527082A JP 52708295 A JP52708295 A JP 52708295A JP H10501792 A JPH10501792 A JP H10501792A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- host
- capsule
- encapsulated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0613—Cells from endocrine organs
- C12N5/0614—Adrenal gland
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.宿主に細胞を移植する方法であって: (a) 該細胞を生体適合性カプセルにカプセル化する工程、 (b) 該細胞を1つ以上の制限条件に十分な期間曝して、制限条件(1つま たは複数)に応答する所望の細胞特性を確立する工程、および (c) 該カプセル化細胞を宿主の移植部位で移植する工程であって、該細胞 が移植後実質的に維持される、工程、 を包含する、方法。 2.前記カプセル化細胞がインビトロで制限条件(1つまたは複数)に曝される 、請求項1に記載の方法。 3.レピシエントの移植部位で移植することによって、前記カプセル化細胞がイ ンビボで制限条件(1つまたは複数)に曝される、請求項1に記載の方法。 4.前記細胞が前記宿主に対して異種であり、そして前記カプセルが免疫隔離性 である、請求項1に記載の方法。 5.少なくとも1つの制限条件が、約40mg/デシリットルから約70mg/デシリット ルまでの範囲のグルコース濃度である、請求項1に記載の方法。 6.少なくとも1つの制限条件が、約40mmHgから約65mmHgまでの範囲の酸素濃度 である、請求項1に記載の方法。 7.少なくとも1つの制限条件が、脳脊髄液または脳実質内の生理ドーパンミン 濃度未満のドーパミン濃度である、請求項1に記載の方法。 8.前記細胞が、副腎のクロム親和性細胞、ベビーハムスター腎細胞、およびP C12細胞からなる群より選択される、請求項3に記載の方法。 9.前記細胞が、PC12細胞であって、そして6ヶ月間以上レピシエントに移植さ れる、請求項8に記載の方法。 10.前記細胞が、副腎のクロム親和性細胞であって、そして4ヶ月間以上レピ シエントに移植される、請求項8に記載の方法。 11.前記細胞が、PC12細胞であって、そして3週間以上レピシエントに移植さ れる、請求項8に記載の方法。 12.前記細胞が、神経伝達物質、鎮痛剤、および成長因子からなる群より選択 される生物学的に活性な分子を産生する、請求項1に記載の方法。 13.前記生物学的に活性な分子が、少なくとも1種のカテコールアミンである 、請求項12に記載の方法。 14.前記カプセルが、脳脊髄液および脳実質からなる群より選択される移植部 位で、宿主に移植される請求項1に記載の方法。 15.前記宿主がヒトである、請求項1に記載の方法。 16.制限条件に応答する所望の細胞特性を示す細胞であって、 (a) 細胞を生体適合性カプセルにカプセル化する工程、および (b) 該カプセル化細胞を霊長類レピシエントの移植部位で少なくとも6ヶ 月間移植して、移植部位で起こる制限条件に応答する所望の細胞特性を確立する 工程であって、該細胞がレピシエントに対して異種である、工程、 によって生産される、細胞。 17.前記細胞が、非霊長類の副腎クロム親和性細胞、ベビーハムスター腎細胞 、およびPC12細胞からなる群より選択される、請求項16に記載の細胞。 18.前記細胞が非霊長類の副腎クロム親和性細胞である、請求項17に記載の 細胞。 19.前記細胞がPC12細胞である、請求項17に記載の細胞。 20.前記所望の細胞特性が、前記細胞のカテコールアミン産出量の変化である 、請求項18または19に記載の細胞。 21.前記所望の細胞特性が、前記細胞のカテコールアミン産出量の増加である 、請求項20に記載の細胞。 22.前記カプセルが、脳脊髄液および脳実質からなる群より選択される移植部 位で移植される、請求項16に記載の細胞。 23.前記宿主がヒトである、請求項16に記載の細胞。 24.異種宿主に細胞を移植する方法であって: (a) 2つ以上の制限条件下で該細胞を培養する工程、 (b) 該細胞を生体適合性カプセルにカプセル化し、さらに該カプセル化細 胞を1つ以上の制限条件に十分な期間曝して、制限条件に応答する所望の細胞特 性を確立する工程、および (c) 宿主の移植部位で該カプセル化細胞を移植する工程であって、該細胞 特性が移植後実質的に維持される、工程、 を包含する、方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/228,403 | 1994-04-15 | ||
US08/228,403 US5550050A (en) | 1994-04-15 | 1994-04-15 | Method for implanting encapsulated cells in a host |
PCT/US1995/004564 WO1995028166A2 (en) | 1994-04-15 | 1995-04-13 | Method for implanting encapsulated cells in a host |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005076076A Division JP2005239726A (ja) | 1994-04-15 | 2005-03-16 | カプセル化細胞の宿主への移植方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10501792A true JPH10501792A (ja) | 1998-02-17 |
Family
ID=22857036
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7527082A Pending JPH10501792A (ja) | 1994-04-15 | 1995-04-13 | カプセル化細胞の宿主への移植方法 |
JP2005076076A Pending JP2005239726A (ja) | 1994-04-15 | 2005-03-16 | カプセル化細胞の宿主への移植方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005076076A Pending JP2005239726A (ja) | 1994-04-15 | 2005-03-16 | カプセル化細胞の宿主への移植方法 |
Country Status (19)
Country | Link |
---|---|
US (1) | US5550050A (ja) |
EP (2) | EP1632238A1 (ja) |
JP (2) | JPH10501792A (ja) |
CN (1) | CN1146155A (ja) |
AU (1) | AU697600B2 (ja) |
BR (1) | BR9507391A (ja) |
CA (1) | CA2187335A1 (ja) |
CZ (1) | CZ300496A3 (ja) |
EE (1) | EE9600147A (ja) |
FI (1) | FI964124A (ja) |
HU (1) | HUT75661A (ja) |
IL (1) | IL113390A0 (ja) |
IS (1) | IS4368A (ja) |
LV (1) | LV11730B (ja) |
NO (1) | NO964358L (ja) |
PL (1) | PL316845A1 (ja) |
SK (1) | SK131696A3 (ja) |
WO (1) | WO1995028166A2 (ja) |
ZA (1) | ZA953126B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009522269A (ja) * | 2005-12-30 | 2009-06-11 | ニューロテック ユーエスエー, インコーポレイテッド | 生物活性分子の送達のための微粒子化デバイスおよびその使用方法 |
JP2012072180A (ja) * | 2003-11-13 | 2012-04-12 | Psivida Inc | 生物浸食性マトリクスコア及び生物浸食性スキンを有する注射可能な持続的放出用の送達用デバイス |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0610441A4 (en) * | 1991-10-29 | 1996-01-10 | Clover Cons Ltd | CROSSLINKABLE POLYSACCHARIDES, POLYCATIONS AND LIPIDS CAN BE USED TO ENCODE AND DISPENSE MEDICINAL PRODUCTS. |
US5908623A (en) * | 1993-08-12 | 1999-06-01 | Cytotherapeutics, Inc. | Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
US5935849A (en) * | 1994-07-20 | 1999-08-10 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
US6392118B1 (en) * | 1994-07-20 | 2002-05-21 | Neurotech S.A. | Mx-1 conditionally immortalized cells |
US5620013A (en) * | 1994-10-21 | 1997-04-15 | American Cyanamid Company | Method for destroying residual lens epithelial cells |
US5762925A (en) * | 1994-11-03 | 1998-06-09 | Sagen; Jacqueline | Preventing opiate tolerance by cellular implantation |
US6495364B2 (en) | 1995-05-23 | 2002-12-17 | Neurotech, S.A. | Mx-1 conditionally immortalized cells |
US5855613A (en) | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
JP4301347B2 (ja) * | 1996-03-14 | 2009-07-22 | ジェネンテク, インコーポレイテッド | Gdnfおよびgdnf受容体の用途 |
US5904144A (en) * | 1996-03-22 | 1999-05-18 | Cytotherapeutics, Inc. | Method for treating ophthalmic diseases |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US6027721A (en) * | 1996-05-20 | 2000-02-22 | Cytotherapeutics, Inc. | Device and method for encapsulated gene therapy |
US6054142A (en) * | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
US6150164A (en) * | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US6074825A (en) * | 1997-07-31 | 2000-06-13 | Maine Medical Center | Stable encapsulated reference nucleic acid and method of making |
WO1999013868A1 (en) * | 1997-09-17 | 1999-03-25 | Alcon Laboratories, Inc. | Methods for treating ocular diseases |
WO1999013726A1 (en) * | 1997-09-19 | 1999-03-25 | University Of South Florida | Neuronal cells and an immunosuppressant and anti-inflammatory factor |
US6638501B1 (en) | 1997-09-29 | 2003-10-28 | Neurospheres Holdings Ltd. | Use of multipotent neural stem cell progeny to augment non-neural tissues |
US6303136B1 (en) * | 1998-04-13 | 2001-10-16 | Neurotech S.A. | Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane |
US6610540B1 (en) * | 1998-11-18 | 2003-08-26 | California Institute Of Technology | Low oxygen culturing of central nervous system progenitor cells |
US6184035B1 (en) | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US6713293B1 (en) | 1999-02-08 | 2004-03-30 | Friedrich Grummt | Encapsulated cells containing an amplified expression vector as a drug delivery device |
IL138990A0 (en) * | 1999-02-12 | 2001-11-25 | Biostream Inc | Matrices for drug delivery and methods for making and using the same |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US6361771B1 (en) | 1999-04-06 | 2002-03-26 | Neurotech S.A. | ARPE-19 as a platform cell line for encapsulated cell-based delivery |
US20070071734A1 (en) * | 1999-04-06 | 2007-03-29 | Weng Tao | ARPE-19 as platform cell line for encapsulated cell-based delivery |
AU4440000A (en) * | 1999-04-30 | 2000-11-17 | Diatranz Limited | Xenotransplant for cns therapy |
US20040213768A1 (en) * | 1999-04-30 | 2004-10-28 | Elliott Robert Bartlett | Preparation for biotransplantation and xenotransplantion and uses thereof |
US20090047325A1 (en) * | 1999-04-30 | 2009-02-19 | Neurotrophincell Pty. Limited | Xenotransplant for cns therapy |
US20050265977A1 (en) * | 1999-04-30 | 2005-12-01 | Elliott Robert B | Xenotransplant for CNS therapy |
DK1248640T3 (da) * | 2000-01-20 | 2007-02-12 | Diabcell Pty Ltd | Xenotransplantation af svineöer og deres fremstilling |
AU2001233168A1 (en) * | 2000-01-31 | 2001-08-07 | Children's Medical Center Corporation | Neural regeneration conduit |
US6719970B1 (en) | 2000-07-10 | 2004-04-13 | Alkermes Controlled Therapeutics, Inc. | Method of generating cartilage |
AU1112202A (en) * | 2000-10-17 | 2002-04-29 | Diatranz Ltd | Preparation and xenotransplantation or porcine islets |
US6538010B1 (en) * | 2000-11-08 | 2003-03-25 | Research Triangle Institute | Compounds and methods for promoting smoking cessation |
EP1414948B1 (en) * | 2001-07-10 | 2009-09-16 | Biogen Idec Inc. | Inhibition of apoptosis process and improvement of cell performance |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
US7332330B2 (en) | 2001-09-11 | 2008-02-19 | Renamed Biologics, Inc. | Device for maintaining vascularization near an implant |
ATE535601T1 (de) * | 2001-09-28 | 2011-12-15 | Diabcell Pty Ltd | Züchtung von fremdtransplantationsmaterial in kultur |
US20030068308A1 (en) * | 2001-10-09 | 2003-04-10 | Jacek Rozga | Intrasplenic encapsulated cell therapy |
NZ515310A (en) * | 2001-11-07 | 2004-08-27 | Diabcell Pty Ltd | Methods of treatment and delivery modes |
US7442546B2 (en) * | 2002-03-15 | 2008-10-28 | The Regents Of The University Of Michigan | Method of modulating inflammatory response |
EP1369491A1 (en) * | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
US20030228261A1 (en) * | 2002-06-05 | 2003-12-11 | Aladar Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
AU2003901325A0 (en) * | 2003-03-21 | 2003-04-03 | Stephen Locarnini | Therapeutic, prophylactic and diagnostic agents |
WO2004084890A1 (en) * | 2003-03-26 | 2004-10-07 | Crc For Asthma Limited | Therapeutic and prophylactic compositions and uses therefor |
WO2004108760A2 (en) | 2003-06-10 | 2004-12-16 | Nsgene A/S | Improved secretion of neublastin |
ATE420160T1 (de) | 2003-06-18 | 2009-01-15 | Genelux Corp | Modifizierte rekombinante vacciniaviren, verwendungen davon |
CA2529573A1 (en) * | 2003-06-24 | 2004-12-29 | Diabcell Pty Limited | Porcine islets cultured with porcine sertoli cells for xenotransplantation |
WO2005020677A1 (en) | 2003-08-29 | 2005-03-10 | The Walter And Eliza Hall Institute Of Medical Research | Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening |
US8066973B2 (en) * | 2003-09-05 | 2011-11-29 | The Ohio State University Research Foundation | Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
US7662362B2 (en) * | 2003-09-05 | 2010-02-16 | The Ohio State University Research Foundation | Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
NZ547185A (en) | 2003-10-20 | 2009-03-31 | Nsgene As | In vivo gene therapy of parkinson's disease |
DE602005010047D1 (de) * | 2004-01-19 | 2008-11-13 | Nsgene As | Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen |
WO2005074923A1 (en) * | 2004-02-03 | 2005-08-18 | Agt Biosciences Limited | Methods and compositions |
CA2561577A1 (en) | 2004-03-30 | 2005-10-13 | Nsgene A/S | Therapeutic use of a growth factor, nsg33 |
EP1766389A4 (en) | 2004-05-12 | 2008-08-27 | Inst Medical W & E Hall | CELL ISOLATION PROCEDURE |
US20090136552A1 (en) * | 2004-07-30 | 2009-05-28 | Mette Gronborg | Growth factors nsg28, nsg30, and nsg32 |
AU2006228873B2 (en) * | 2005-04-01 | 2011-08-18 | Nsgene A/S | A human immortalised neural precursor cell line |
JP5010584B2 (ja) * | 2005-05-17 | 2012-08-29 | エヌエスゲーネ・アクティーゼルスカブ | 活性因子によって生物を治療する移植可能な療法システム |
NZ540597A (en) * | 2005-06-08 | 2007-02-23 | Neurotrophincell Pty Ltd | A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells |
WO2006135985A1 (en) | 2005-06-24 | 2006-12-28 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
EP1940471A1 (en) * | 2005-10-28 | 2008-07-09 | NsGene A/S | IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF |
DE102005061801A1 (de) * | 2005-12-23 | 2007-06-28 | BSH Bosch und Siemens Hausgeräte GmbH | Einschubdosiersystem für Haushaltsgeräte |
TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
WO2008011006A2 (en) | 2006-07-18 | 2008-01-24 | University Of Utah Research Foundation | Methods for treating pain and screening analgesic compounds |
CA2715080C (en) | 2007-09-28 | 2021-09-28 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
US20090090214A1 (en) * | 2007-10-04 | 2009-04-09 | Chung Yuan Christian University | Method for forming nano-scale metal particles |
US20090196854A1 (en) * | 2008-02-04 | 2009-08-06 | Kytos Biosystems S.A. | Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery |
US20100021437A1 (en) * | 2008-04-07 | 2010-01-28 | The McLean Hospital Corporation Whitehead Institute for Biomedical Research | Neural stem cells derived from induced pluripotent stem cells |
JP5897335B2 (ja) | 2009-01-23 | 2016-03-30 | エヌエスジーン・アクティーゼルスカブNsGene A/S | 改良された細胞株及びカプセル化細胞生体送達におけるその使用 |
US20120021039A1 (en) | 2009-01-23 | 2012-01-26 | Nsgene A/S | Expression of neuropeptides in mammalian cells |
US20150024024A1 (en) * | 2009-04-23 | 2015-01-22 | Neurotech Usa, Inc. | Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses Thereof |
FR2948125B1 (fr) | 2009-07-17 | 2011-08-26 | Zoran Dermanovic | Procedes d'etablissement de symbioses |
US20110091427A1 (en) * | 2009-10-02 | 2011-04-21 | Baxter International Inc. | Methods for treating a kidney injury |
CA2776748A1 (en) * | 2009-10-08 | 2011-04-14 | Neurotech Usa, Inc. | Use of pedf in an encapsulated cell-based delivery system |
AU2011307488B2 (en) | 2010-10-01 | 2015-08-20 | Hoba Therapeutics Aps | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
CN103502464B (zh) | 2010-12-02 | 2016-03-23 | 神经技术美国有限公司 | 分泌抗血管生成抗体支架和可溶性受体的细胞系及其用途 |
JP2012215543A (ja) * | 2011-03-31 | 2012-11-08 | Sony Corp | 個体情報の判定方法、個体情報判定装置、電子機器及び個体情報判定プログラム |
EP2753347B1 (en) | 2011-09-05 | 2016-08-03 | NsGene A/S | Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain |
EP2817014A2 (en) | 2012-02-21 | 2014-12-31 | Baxter International Inc | Pharmaceutical composition comprising cd34+ cells |
US20150150796A1 (en) | 2012-05-30 | 2015-06-04 | Neurotech Usa, Inc. | Cryopreserved Implantable Cell Culture Devices and Uses Thereof |
JP6234485B2 (ja) | 2013-03-07 | 2017-11-22 | ヴィアサイト インコーポレイテッド | 3次元大収容力細胞封入デバイスアセンブリー |
EP3003344B1 (en) | 2013-05-31 | 2020-11-25 | University of Utah Research Foundation | Conotoxin peptides, pharmaceutical compositions and uses thereof |
JP2016531149A (ja) | 2013-09-11 | 2016-10-06 | ニューロテック ユーエスエー, インコーポレイテッド | カプセル化細胞療法カートリッジ |
CA2986769A1 (en) | 2015-05-27 | 2016-12-01 | Neurotech Usa, Inc. | Use of encapsulated cell therapy for treatment of ophthalmic disorders |
JP6877419B2 (ja) | 2015-10-27 | 2021-05-26 | ザ ユニバーシティー オブ クイーンズランド | 治療の方法およびそのために有用な剤 |
WO2022011081A1 (en) | 2020-07-09 | 2022-01-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cell lines that produce human retinoschisin proteins and uses thereof |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
US4409331A (en) * | 1979-03-28 | 1983-10-11 | Damon Corporation | Preparation of substances with encapsulated cells |
US4298002A (en) * | 1979-09-10 | 1981-11-03 | National Patent Development Corporation | Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation |
US4353888A (en) * | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
NO163060C (no) * | 1981-03-13 | 1990-03-28 | Damon Biotech Inc | Fremgangsmaate for fremstilling av substanser som dannes av levende celler som produserer interferoner eller antistoffer. |
JPS5876086A (ja) * | 1981-10-28 | 1983-05-09 | Ajinomoto Co Inc | 浮遊性動物細胞の培養法 |
US4479796A (en) * | 1982-11-15 | 1984-10-30 | Medtronic, Inc. | Self-regenerating drug administration device |
EP0127989A3 (en) * | 1983-06-01 | 1986-03-26 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4689293A (en) * | 1983-06-06 | 1987-08-25 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4806355A (en) * | 1983-06-06 | 1989-02-21 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
JPS60141286A (ja) * | 1983-12-28 | 1985-07-26 | Ajinomoto Co Inc | 動物細胞の培養方法および装置 |
US4749620A (en) * | 1984-02-15 | 1988-06-07 | Massachusetts Institute Of Technology | Encapsulated active material system |
CA1215922A (en) * | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
GB8500121D0 (en) * | 1985-01-03 | 1985-02-13 | Connaught Lab | Microencapsulation of living cells |
US4868121A (en) | 1985-02-07 | 1989-09-19 | Mcdonnell Douglas Corporation | Islet isolation process |
US4902295A (en) * | 1985-08-26 | 1990-02-20 | Hana Biologics, Inc. | Transplantable artificial tissue |
US4753635A (en) | 1986-05-23 | 1988-06-28 | Jacqueline Sagen | Inducing analgesia by implantation of cells releasing neuroactive substances |
US5026365A (en) * | 1987-04-29 | 1991-06-25 | The University Of Massachusetts | Method and apparatus for therapeutically treating immunological disorders and disease states |
DE3724798A1 (de) * | 1987-07-27 | 1989-02-09 | Mengele & Soehne Masch Karl | Erntevorsatz an feldhaeckslern |
US4942129A (en) * | 1987-07-28 | 1990-07-17 | Queen's University At Kingston | Multiple membrane microencapsulation |
US5106627A (en) * | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5182111A (en) * | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
WO1993000127A1 (en) | 1991-06-28 | 1993-01-07 | Brown University Research Foundation | Neural implant system |
US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
KR0132666B1 (en) * | 1989-03-14 | 1998-04-14 | Hitachi Kk | Method for controlling cultivation conditions for animal cells |
US5002661A (en) * | 1989-08-25 | 1991-03-26 | W. R. Grace & Co.-Conn. | Artificial pancreatic perfusion device |
WO1991009119A1 (en) * | 1989-12-13 | 1991-06-27 | Trancel Corporation | Improved alginate microcapsules, methods of making and using same |
WO1991010470A1 (en) * | 1990-01-08 | 1991-07-25 | Brown University Research Foundation | Devices and methods for enhanced delivery of active factors |
US5084350A (en) * | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
AU8649391A (en) | 1990-08-15 | 1992-03-17 | University Of Miami | Autotransplantation of schwann cells to promote nervous system repair |
DK0585368T3 (da) * | 1991-04-25 | 1998-03-16 | Univ Brown Res Found | Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter |
WO1993022427A1 (en) * | 1992-04-24 | 1993-11-11 | Somatix Therapy Corporation | Method of culturing viable cells and method of regulating the level of a compound in a body fluid |
JPH08500033A (ja) | 1992-07-29 | 1996-01-09 | ワシントン・ユニバーシティ | 生細胞移植のためのポーチの使用 |
EP0708670A4 (en) | 1993-06-23 | 1998-07-01 | Cytotherapeutics Inc | METHOD AND APPARATUS FOR HERMETICALLY CLOSING IMPLANTABLE MEMBRANE ENCAPSULATING DEVICES |
DK0802800T3 (da) | 1993-08-12 | 2002-10-07 | Neurotech Sa | Biokompatible immunoisolatoriske kapsler indeholdende genetisk ændrede celler for levering af biologisk aktive molekyler |
-
1994
- 1994-04-15 US US08/228,403 patent/US5550050A/en not_active Expired - Lifetime
-
1995
- 1995-04-13 CN CN95192579A patent/CN1146155A/zh active Pending
- 1995-04-13 EP EP05023484A patent/EP1632238A1/en not_active Withdrawn
- 1995-04-13 JP JP7527082A patent/JPH10501792A/ja active Pending
- 1995-04-13 CZ CZ963004A patent/CZ300496A3/cs unknown
- 1995-04-13 BR BR9507391A patent/BR9507391A/pt not_active Application Discontinuation
- 1995-04-13 CA CA002187335A patent/CA2187335A1/en not_active Abandoned
- 1995-04-13 PL PL95316845A patent/PL316845A1/xx unknown
- 1995-04-13 EP EP95916970A patent/EP0756487A1/en not_active Ceased
- 1995-04-13 SK SK1316-96A patent/SK131696A3/sk unknown
- 1995-04-13 HU HU9602850A patent/HUT75661A/hu unknown
- 1995-04-13 WO PCT/US1995/004564 patent/WO1995028166A2/en not_active Application Discontinuation
- 1995-04-13 EE EE9600147A patent/EE9600147A/xx unknown
- 1995-04-13 AU AU23829/95A patent/AU697600B2/en not_active Ceased
- 1995-04-14 IL IL11339095A patent/IL113390A0/xx unknown
- 1995-04-18 ZA ZA953126A patent/ZA953126B/xx unknown
-
1996
- 1996-10-01 IS IS4368A patent/IS4368A/is unknown
- 1996-10-14 NO NO964358A patent/NO964358L/no not_active Application Discontinuation
- 1996-10-14 FI FI964124A patent/FI964124A/fi unknown
- 1996-11-15 LV LVP-96-434A patent/LV11730B/en unknown
-
2005
- 2005-03-16 JP JP2005076076A patent/JP2005239726A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012072180A (ja) * | 2003-11-13 | 2012-04-12 | Psivida Inc | 生物浸食性マトリクスコア及び生物浸食性スキンを有する注射可能な持続的放出用の送達用デバイス |
JP2009522269A (ja) * | 2005-12-30 | 2009-06-11 | ニューロテック ユーエスエー, インコーポレイテッド | 生物活性分子の送達のための微粒子化デバイスおよびその使用方法 |
Also Published As
Publication number | Publication date |
---|---|
PL316845A1 (en) | 1997-02-17 |
NO964358L (no) | 1996-12-13 |
AU2382995A (en) | 1995-11-10 |
LV11730B (en) | 1998-02-20 |
CA2187335A1 (en) | 1995-10-26 |
IS4368A (is) | 1996-10-01 |
EP1632238A1 (en) | 2006-03-08 |
US5550050A (en) | 1996-08-27 |
MX9604832A (es) | 1998-06-28 |
FI964124A0 (fi) | 1996-10-14 |
WO1995028166A3 (en) | 1995-11-09 |
JP2005239726A (ja) | 2005-09-08 |
FI964124A (fi) | 1996-10-14 |
EP0756487A1 (en) | 1997-02-05 |
IL113390A0 (en) | 1995-07-31 |
EE9600147A (et) | 1997-04-15 |
HU9602850D0 (en) | 1996-12-30 |
AU697600B2 (en) | 1998-10-08 |
SK131696A3 (en) | 1997-06-04 |
WO1995028166A2 (en) | 1995-10-26 |
BR9507391A (pt) | 1997-09-16 |
HUT75661A (en) | 1997-05-28 |
LV11730A (lv) | 1997-04-20 |
CZ300496A3 (en) | 1997-03-12 |
ZA953126B (en) | 1996-01-04 |
NO964358D0 (no) | 1996-10-14 |
CN1146155A (zh) | 1997-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10501792A (ja) | カプセル化細胞の宿主への移植方法 | |
US5800828A (en) | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products | |
JP4098355B2 (ja) | 遺伝的に改変された細胞を含む生体適合性免疫隔離カプセル | |
Sagot et al. | Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse | |
US5800829A (en) | Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core | |
US6264941B1 (en) | Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | |
AU632827B2 (en) | Neurological therapy system | |
KR19990022414A (ko) | 통증 치료용 진통 화합물을 생성하는 세포주 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20041116 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050316 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20050526 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050425 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20050728 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060407 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060407 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060607 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060614 |